• Explore /
  • Poster
  • / Prospective phase II study of inoperable pancreatic adenocarcinoma with neoadjuvant gemcitabine, docetaxel, and capecitabine (GTX).

Prospective phase II study of inoperable pancreatic adenocarcinoma with neoadjuvant gemcitabine, docetaxel, and capecitabine (GTX).

Abstract Poster

Authors

null

Anthony Paul Gulati

Columbia University Medical Center, New York, NY

Anthony Paul Gulati , Stephen M. Schreibman , Beth Schrope , James A. Lee , John Allendorf , John A. Chabot , Dawn Tsushima , Kelley B. Mowatt , Anna Oprescu , Kyung Chu , William H. Sherman , Ronald D. Ennis , Yoomi Lee , Robert Lance Fine

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT00869258

Citation

J Clin Oncol 32, 2014 (suppl 3; abstr 274)

DOI

10.1200/jco.2014.32.3_suppl.274

Abstract #

274

Poster Bd #

B47

Abstract Disclosures

Similar Posters

First Author: Andrew L. Coveler

First Author: Grace E. Ryan

First Author: Emerson Yu-sheng Chen

First Author: Rafael Alvarez-Gallego